WEZLANA
WEZLANA
Approved
DIN Number
02553309
Drug Class
Human
Market Date
Feb 5, 2025
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02553309
AIG Number0152506001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AC05 USTEKINUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:24.20.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
USTEKINUMABActive
Strength: 90 MG / 1 ML
Monograph: USTEKINUMAB